We are live on ! Find out more
HAE icon

Haemonetics
HAE

170 hedge funds and large institutions have $1.86B invested in Haemonetics in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 55 increasing their positions, 75 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less capital invested

Capital invested by funds: $1.95B → $1.86B (-$86.6M)

3% less funds holding

Funds holding: 175 → 170 (-5)

3.54% less ownership

Funds ownership: 107.15% → 103.61% (-3.5%)

16% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 19

27% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 75

Holders
170
Holders Change
-5
Holders Change %
-2.86%
% of All Funds
4.93%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
55
Reduced
75
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$35.6M
2
VNIM
Vaughan Nelson Investment Management
Texas
+$8.49M
3
BCIM
Black Creek Investment Management
Ontario, Canada
+$7.19M
4
UBS AM
UBS AM
Illinois
+$6.81M
5
PTC
Petrus Trust Company
Texas
+$5.02M

Top Sellers

1
CCM
Camber Capital Management
Massachusetts
-$35.3M
2
Nordea Investment Management
Nordea Investment Management
Sweden
-$15.1M
3
Neuberger Berman Group
Neuberger Berman Group
New York
-$13.1M
4
PIM
Perkins Investment Management
Illinois
-$10.4M
5
Norges Bank
Norges Bank
Norway
-$9.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
Los Angeles Capital Management
176
Los Angeles Capital Management
California
– -$1.3M -36,855 Closed
Susquehanna International Group
177
Susquehanna International Group
Pennsylvania
– -$882K -24,992 Closed
ARC
178
Absolute Return Capital
Massachusetts
– -$581K -16,460 Closed
Tudor Investment Corp
179
Tudor Investment Corp
Connecticut
– -$356K -10,100 Closed
RPAM
180
Rhenman & Partners Asset Management
Sweden
– -$354K -10,047 Closed
B
181
Baird
Wisconsin
– -$205K -5,810 Closed
VFA
182
Virtus Fund Advisers
Connecticut
– -$157K -4,441 Closed
BC
183
Broadfin Capital
New York
– -$127K -3,600 Closed
PAM
184
Paradigm Asset Management
New York
– -$125K -3,550 Closed
Group One Trading
185
Group One Trading
Illinois
– -$46K -1,306 Closed
BRWA
186
B. Riley Wealth Advisors
Florida
– -$16K -453 Closed
GSC
187
Ground Swell Capital
South Carolina
– -$9K -247 Closed
NES
188
New England Securities
New York
– -$5K -150 Closed
Bessemer Group
189
Bessemer Group
New Jersey
– -$1K -39 Closed
4 5 6 7
8

HAE Hedge Fund Activity: Q3 2014 in Review

170 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q3 2014, worth a combined $1.86B — down 4.5% from $1.95B a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of HAE and 16 opened new positions — a net loss of 3 holders — while 75 trimmed existing stakes and 55 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $35.6M. The largest seller was Camber Capital Management, exiting entirely with an estimated $35.3M sold.

  • 170 institutional investors held Haemonetics (HAE) as of Q3 2014, down from 175 in Q2 2014.
  • Funds reported $1.86B of Haemonetics stock for Q3 2014, down 4.5% quarter-over-quarter.
  • 16 funds opened new Haemonetics positions in Q3 2014 and 19 closed out, a net change of -3 holders.
  • The largest Haemonetics buyer in Q3 2014 was T. Rowe Price Associates, an estimated $35.6M added.
  • The largest Haemonetics seller in Q3 2014 was Camber Capital Management, an estimated $35.3M sold.

Based on aggregated 13F filings for Q3 2014.